- $360.17m
- $450.86m
- $54.33m
- 16
- 21
- 48
- 17
Annual balance sheet for Carlsmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 7.22 | 40.1 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 3.17 | 6.77 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 11.8 | 49.4 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 2.24 | 1.9 |
| Other Long Term Assets | ||
| Total Assets | 14 | 51.8 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Current Liabilities | 7.44 | 8.82 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 16.8 | 26.2 |
| Non Redeemable Preferred Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | -2.75 | 25.6 |
| Total Liabilities & Shareholders' Equity | 14 | 51.8 |
| Total Common Shares Outstanding |